Product Expansion Perrigo's strategic acquisition of OTC products from Aspen Pharma and the sale of its Dermacosmetics business indicates a focus on expanding and refining its self-care and consumer health portfolio, presenting opportunities to introduce complementary health and wellness solutions to existing and new retail partners.

Retail Partnership Growth As a manufacturer of store brand OTC products and self-care solutions sold under retailers’ private labels, Perrigo’s collaboration model suggests a strong potential for developing customized health products and expanding private label offerings with retail chains seeking reliable healthcare brand partnerships.

Digital Security Focus Facing cybersecurity incidents targeting employee email accounts, Perrigo is likely investing more in cybersecurity and enterprise tech solutions, creating a demand for advanced security and IT infrastructure services among similar pharmaceutical manufacturers seeking to bolster their digital defenses.

Market Diversification Perrigo’s international expansion through acquisitions in Australia and New Zealand demonstrates openness to market diversification, offering opportunities to supply localized healthcare products, regulations navigation services, and regional market entry strategies to other global healthcare firms.

Innovation & Partnerships Recognition through awards for academic partnerships highlights Perrigo’s commitment to innovation and professional development, which could be an avenue for promoting collaborative R&D, digital health solutions, and employee engagement tools to companies seeking to enhance their innovation pipelines.